Geode Capital Management LLC lifted its position in Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) by 41.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 226,083 shares of the ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

Srinivas RaoM.D., Ph.D. succeeds as sole Chief Executive Officer- Kevin Craig, M.D. promoted to Chief Medical Officer- Glenn Short, Ph.D.

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder ...

In the MAD-2 trial, RAP-219 was observed to be generally well tolerated with faster titration and higher exposures than in the initial MAD trial Data underscore the potential broad therapeutic index ...

Mytos’ technology will automate the manufacturing of neuronal precursors for Aspen's autologous cell therapy for the brain disorder.

On track to report data from Phase 1 clinical trial evaluating VG-3927 for the treatment of Alzheimer’s disease in 1Q 2025 –– Final analysis ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

BrainSight AI raised $5 million in pre-series A funding round. With plans to expand in India and pursue FDA certification.

The Miami Neuroscience Center at Larkin Hospital in South Miami has successfully performed its first focused ultrasound ...

Mytos, an innovative leader in automated cell manufacturing, has entered into a manufacturing collaboration with Aspen ...